John D. Imig
机构: University of Arkansas for Medical Sciences (UAMS)
每年引用次数
引用次数
引用: 19,003
H-指数: 78
I10-指数 : 217
出版物: 501
High fat diet induces insulin resistance and heightened renal inflammation in angiotensin II hypertensive rats
Jeffrey E. Quigley , Ahmed A. Elmarakby , John D. Imig
The FASEB Journal 21 ( 5)
2007
Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.
John D. Imig
Pharmacology & Therapeutics 192 1 -19
27
2018
ET-1-induced contraction of renal afferent arterioles of Dahl salt-sensitive rats is impaired by targeted modification of a p66 Shc regulatory phosphorylation site
Andrey Sorokin , Bradley Miller , Aron M. Geurts , John D. Imig
Life Sciences 93
2013
Azilsartan decreases renal and cardiovascular injury in the spontaneously hypertensive obese rat
Md. Abdul Hye Khan , Jan Neckář , Breana Cummens , Geneva M. Wahl
Cardiovascular Drugs and Therapy 28 ( 4) 313 -322
16
2014
Age-related alterations in NOS and oxidative stress in mesenteric arteries from male and female rats.
Jennifer C. Sullivan , Elizabeth Dabbs Loomis , Matthew Collins , John D. Imig
Journal of Applied Physiology 97 ( 4) 1268 -1274
21
2004
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting
Youfei Guan , Yahua Zhang , Jing Wu , Zhonghua Qi
Journal of Clinical Investigation 117 ( 9) 2496 -2505
83
2007
The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction.
Xueying Zhao , Edward W. Inscho , Muralidhar Bondlela , John R. Falck
American Journal of Physiology-heart and Circulatory Physiology 281 ( 5)
43
2001
Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats
Bradley S. Miller , Shoshana R. Blumenthal , Alexey Shalygin , Kevin D. Wright
Diabetes 67 ( 11) 2206 -2212
5
2018
Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans
Mahesha H. Gangadhariah , Blake W. Dieckmann , Louise Lantier , Li Kang
Diabetologia 60 ( 6) 1066 -1075
18
2017
Thioredoxin-interacting protein is required for endothelial NLRP3 inflammasome activation and cell death in a rat model of high-fat diet
Islam N. Mohamed , Sherif S. Hafez , Arwa Fairaq , Adviye Ergul
Diabetologia 57 ( 2) 413 -423
140
2014
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
Md Abdul Hye Khan , Lauren Kolb , Melissa Skibba , Markus Hartmann
Diabetologia 61 ( 10) 2235 -2246
18
2018
PPAR-α Activator Fenofibrate Increases Renal CYP-Derived Eicosanoid Synthesis and Improves Endothelial Dilator Function in Obese Zucker Rats
Xueying Zhao , Jeffrey E. Quigley , Jianghe Yuan , Mong-Heng Wang
American Journal of Physiology-heart and Circulatory Physiology 290 ( 6)
43
2006
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.
Dexter L. Lee , Lashon C. Sturgis , Hicham Labazi , James B. Osborne
American Journal of Physiology-heart and Circulatory Physiology 290 ( 3)
287
2006
Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3
Jan Neckář , Anna Hsu , Md. Abdul Hye Khan , Garrett J. Gross
American Journal of Physiology-heart and Circulatory Physiology 315 ( 5)
10
2018
Regulation of Cardiac Mast Cell Maturation and Function by the Neurokinin-1 Receptor in the Fibrotic Heart.
Alexander Widiapradja , Edward J. Manteufel , Heather M. Dehlin , James Pena
Scientific Reports 9 ( 1) 11004
7
2019
Development of Epoxyeicosatrienoic Acid Analogs with in Vivo Anti-Hypertensive Actions
John D. Imig , Ahmed Elmarakby , Kasem Nithipatikom , Shouzou Wei
Frontiers in Physiology 1 157 -157
43
2010
Immune and Inflammatory Role in Renal Disease
John D. Imig , Michael J. Ryan
Comprehensive Physiology 3 ( 2) 957 -976
161
2013
Cytochrome P450 and Lipoxygenase Metabolites on Renal Function
John D. Imig , Md. Abdul Hye Khan
Comprehensive Physiology 6 ( 1) 423 -441
13
2015
Cardiovascular Therapeutic Aspects of Soluble Epoxide Hydrolase Inhibitors
John D. Imig
Cardiovascular Drug Reviews 24 ( 2) 169 -188
99
2006
Soluble Epoxide Inhibition Is Protective Against Cerebral Ischemia via Vascular and Neural Protection
Alexis N Simpkins , R Daniel Rudic , Derek A Schreihofer , Sid Roy
The American Journal of Pathology 174 ( 6) 2086 -2095
90
2009